LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of biosimulation, simulation-enabled performance and intelligence solutions, and ...
In recent years, artificial intelligence (AI) has made significant strides in transforming various domains, from healthcare to finance. One area that is rapidly gaining attention is business ...
Constantine Davides, an analyst from JMP Securities, has initiated a new Hold rating on Simulations Plus (SLP). Constantine Davides has given his Hold rating due to a combination of factors including ...
Bolstered by fast processing speeds and cheap memory, simulation has become far more accessible than in the past. Thus, the development tool has transformed product development. Simulation has ...
Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced ...
Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today hosted its ...
Four student teams from Greenville Technical College’s Management program recently ranked in the Global Top 100 of the GLO-BUS Business Strategy Simulation, an internationally recognized, highly ...
RESEARCH TRIANGLE, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of biosimulation, simulation-enabled performance and intelligence solutions, and ...
A substantial insider move unfolded on October 21, as DiBella, Business Unit President at Simulations Plus (NASDAQ:SLP), reported the acquisition of stock options for 7,500 shares in an SEC filing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results